How A Larger Biopharma Is Preparing To Get Back To The Office
Source: Life Science Leader
In this executive virtual roundtable (EVR) segment, Britt Byers, SVP of human resources for Kyowa Kirin North America, a global biopharmaceutical company, discusses plans for returning to in-office operations in the United States, and some of the methodology used to make the decision.
This website uses cookies to ensure you get the best experience on our website. Learn more